<p>The dot plots of CSF biomarkers in CN and AD subtypes. Bars indicates median and IQR. (A) CSF Aβ<sub>1–42</sub>, (B) CSF t-tau, (C) CSF p-tau, (D) t-tau/Aβ<sub>1–42</sub> ratio, (E) p-tau/Aβ<sub>1–42</sub> ratio. CN, Cognitively normal; AD, Alzheimer’s disease; BI, Both impaired; HA, Hippocampal atrophy only; CA, Cortical atrophy only; BS, Both spared; CSF, Cerebrospinal fluid; Aβ<sub>1–42</sub> = Amyloid-β 1–42 peptide; t-tau, total tau; p-tau, phosphorylated tau.</p
The aim of this study was to test the diagnostic value of cerebrospinal fluid (CSF) beta-amyloid (Aβ...
Alzheimer's disease(AD) is a neurodegenerative disorder characterized by the presence of extracellul...
Alzheimer's disease(AD) is a neurodegenerative disorder characterized by the presence of extracellul...
Abnormal levels of beta amyloid (Aβ42) and tau protein concentrations in the cerebral spinal fluid (...
Abnormal levels of beta amyloid (Aβ42) and tau protein concentrations in the cerebral spinal fluid (...
Cerebrospinal fluid (CSF) biomarkers may be used to identify and monitor pathological processes in t...
of the key biological forms of -amyloid protein in brain tissue that inversely reflects brain amyloi...
The diagnostic accuracy of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) must be...
Cerebrospinal fluid (CSF) samples from 21 patients with a clinical diagnosis of Alzheimer's disease ...
<p>(A) The levels of CSFΑβ40 were significantly lower in patients with AD and DLB compared to normal...
Background: Alzheimer’s disease dementia (ADD) may manifest with atypical phenotypes, resembling beh...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the presence of extracellu...
Abstract The cerebrospinal fluid (CSF) biochemical markers (biomarkers) Amyloidβ 42 (Aβ42), total Ta...
The National Institute on Aging-Alzheimer's Association (NIA-AA) guidelines for Alzheimer's disease ...
The aim of this study was to test the diagnostic value of cerebrospinal fluid (CSF) beta-amyloid (Aβ...
Alzheimer's disease(AD) is a neurodegenerative disorder characterized by the presence of extracellul...
Alzheimer's disease(AD) is a neurodegenerative disorder characterized by the presence of extracellul...
Abnormal levels of beta amyloid (Aβ42) and tau protein concentrations in the cerebral spinal fluid (...
Abnormal levels of beta amyloid (Aβ42) and tau protein concentrations in the cerebral spinal fluid (...
Cerebrospinal fluid (CSF) biomarkers may be used to identify and monitor pathological processes in t...
of the key biological forms of -amyloid protein in brain tissue that inversely reflects brain amyloi...
The diagnostic accuracy of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) must be...
Cerebrospinal fluid (CSF) samples from 21 patients with a clinical diagnosis of Alzheimer's disease ...
<p>(A) The levels of CSFΑβ40 were significantly lower in patients with AD and DLB compared to normal...
Background: Alzheimer’s disease dementia (ADD) may manifest with atypical phenotypes, resembling beh...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the presence of extracellu...
Abstract The cerebrospinal fluid (CSF) biochemical markers (biomarkers) Amyloidβ 42 (Aβ42), total Ta...
The National Institute on Aging-Alzheimer's Association (NIA-AA) guidelines for Alzheimer's disease ...
The aim of this study was to test the diagnostic value of cerebrospinal fluid (CSF) beta-amyloid (Aβ...
Alzheimer's disease(AD) is a neurodegenerative disorder characterized by the presence of extracellul...
Alzheimer's disease(AD) is a neurodegenerative disorder characterized by the presence of extracellul...